Cost and impact of scaling up female genital mutilation prevention and care programs: Estimated resource requirements and impact on incidence and prevalence

Autor: Howard S. Friedman, Berhanu Legesse, William Winfrey, Itamar Katz, Maria Nadia Carvalho, Nafissatou J. Diop, Rachel Sanders
Rok vydání: 2021
Předmět:
Female circumcision
Resource (biology)
Epidemiology
Science
Legislation
Social Sciences
Community Based Intervention
Global Health
Geographical locations
Resource Allocation
Sexual and Gender Issues
03 medical and health sciences
0302 clinical medicine
Sociology
Environmental health
Medicine and Health Sciences
Prevalence
Humans
Community Health Services
030212 general & internal medicine
Health Systems Strengthening
Activity-based costing
Average cost
Psychological and Psychosocial Issues
Health Care Policy
030219 obstetrics & reproductive medicine
Multidisciplinary
Incidence
Incidence (epidemiology)
Female Genital Mutilation
Secondary data
Health Care Costs
Investment (macroeconomics)
United States
Health Care
Work (electrical)
North America
Circumcision
Female
Medicine
Law and Legal Sciences
Female
Business
People and places
Research Article
Zdroj: PLoS ONE
PLoS ONE, Vol 16, Iss 1, p e0244946 (2021)
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0244946
Popis: Purpose SDG 5.3 targets include eliminating harmful practices such as Female Genital Mutilation (FGM). Limited information is available about levels of investment needed and realistic estimates of potential incidence change. In this work, we estimate the cost and impact of FGM programs in 31 high burden countries. Methods This analysis combines program data, secondary data analysis, and population-level costing methods to estimate cost and impact of high and moderate scaleup of FGM programs between 2020 and 2030. Cost per person or community reached was multiplied by populations to estimate costs, and regression analysis was used to estimate new incidence rates, which were applied to populations to estimate cases averted. Results Reaching the high-coverage targets for 31 countries by 2030 would require an investment of US$ 3.3 billion. This scenario would avert more than 24 million cases of FGM, at an average cost of US$ 134 per case averted. A moderate-coverage scenario would cost US$ 1.6 billion and avert more than 12 million cases of FGM. However, average cost per case averted hides substantial variation based on country dynamics. The most cost-effective investment would be in countries with limited historic change in FGM incidence, with the average cost per case averted between US$ 3 and US$ 90. The next most effective would be those with high approval for FGM, but a preexisting trend downward, where cost per case averted is estimated at around US$ 240. Interpretation This analysis shows that although data on FGM is limited, we can draw useful findings from population-level surveys and program data to guide resource mobilization and program planning.
Databáze: OpenAIRE
Externí odkaz: